Nonclinical data supporting orphan medicinal product designations: lessons from rare neurological conditions

Tools

Item Type:	Review
Title:	Nonclinical data supporting orphan medicinal product designations: lessons from rare neurological conditions
Creators Name:	Sheean, M.E., Stoyanova-Beninska, V., Capovilla, G., Duarte, D., Hofer, M.P., Hoffmann, M., Magrelli, A., Mariz, S., Tsigkos, S., Shaili, E., Polsinelli, B., Ricciardi, M., Bonelli, M., Balabanov, P., Larsson, K. and Sepodes, B.
Abstract:	Here, we provide an in-depth literature and experience-based review of nonclinical models and data used to support orphan medicinal product designations (OMPDs) in rare neurodegenerative conditions. The Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency updates its assessment processes based on scientific progress and aims to provide transparent criteria required in support of OMPDs. Thus, we also provide an updated analysis of existing nonclinical models in selected conditions and identify key features of nonclinical studies that are crucial for the support of OMPDs. This could not only inform future drug development in rare neurological conditions, but also indicate areas where the use of nonclinical models can be made more efficient.
Keywords:	Animal Disease Models, Nervous System Diseases, Orphan Drug Production, Preclinical Drug Evaluation, Rare Diseases, Animals
Source:	Drug Discovery Today
ISSN:	1359-6446
Publisher:	Elsevier
Volume:	23
Number:	1
Page Range:	26-48
Date:	January 2018
Official Publication:	https://doi.org/10.1016/j.drudis.2017.09.015
PubMed:	View item in PubMed

Repository Staff Only: item control page